We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

Tue, 02nd Nov 2021 15:20

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

MJ Gleeson PLC - Sheffield, England-based housebuilder - Mark Knight, managing director of Gleeson Homes, buys 18,795 shares at GBP7.94, worth GBP149,232, on Monday. Knight now has 33,682 shares, a 0.1% stake.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - Non-Executive Chair Bill Russell buys 8,200 shares at USD12.37, worth USD101,393, in the US on Friday last week. Now has 53,507 shares, a 0.1% stake.

----------

Riverstone Credit Opportunities Income PLC - aims to generate returns by making loans to companies in energy sector - Director Reuben Jeffery buys 50,000 shares at USD0.86, worth USD43,130, on Monday.

----------

International Biotechnology Trust PLC - investment trust run by SV Health Managers LLP - Non-Executive Director Patrick Magee buys 4,000 shares at 735 pence, worth GBP29,400, on Tuesday. Now has 7,500 shares.

----------

Headlam Group PLC - Birmingham-based floorcoverings distributor - Independent Non-Executive Director Stephen Bird buys 5,000 shares at 462.60p, worth GBP23,130, on Monday.

----------

Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 100,000 shares via Vulpes Life Sciences Fund at 19 pence, worth about GBP19,000, on Friday last week. Vulpes now has 117.3 million shares, a 14.4% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
18 Apr 2024 14:12

UK shareholder meetings calendar - next 7 days

22 Feb 2024 14:26

UK earnings, trading statements calendar - next 7 days

19 Jan 2024 15:35

UK dividends calendar - next 7 days

14 Dec 2023 15:47

UK dividends calendar - next 7 days

20 Nov 2023 14:46

TRADING UPDATES: Origin Enterprises kicks off EUR20 million buyback

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.